Harvard Bioscience (HBIO) Goodwill (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Goodwill data on file, last reported at $9.4 million in Q1 2026.

• Goodwill for Q1 2026 came in at $9.4 million, up 4.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 4.6% YoY), and the FY2025 annual result was $9.6 million, down 83.03% from the prior year.
• Goodwill slipped to $9.4 million in Q1 2026 per HBIO's latest filing, from $9.6 million in the prior quarter.
• Over five years, Goodwill peaked at $57.4 million in Q3 2024 and troughed at $9.0 million in Q1 2025.
• A 5-year average of $42.7 million and a median of $56.3 million in 2022 frame the typical range for Goodwill.
• The sharpest annual moves came in 2025 and 2026: Goodwill sank 84.2% in 2025, then climbed 4.6% in 2026.
• A 5-year view of Goodwill shows it stood at $56.3 million in 2022, then gained by 1.43% to $57.1 million in 2023, then declined by 1.3% to $56.3 million in 2024, then sank by 83.03% to $9.6 million in 2025, then fell by 1.96% to $9.4 million in 2026.
• Business Quant data shows HBIO's Goodwill at $9.4 million in Q1 2026, $9.6 million in Q4 2025, and $9.5 million in Q3 2025.